Hpv Vaccine Dose

HPV research bolsters case for vaccine as misinformation battle intensifies

HPV vaccination reduces the incidence of cervical cancer by about 80 per cent in people vaccinated at or before the age of 16, according to findings published Monday in two Cochrane reviews

HPV vaccine isn't just for teens: Why adults should get the shot too

As cervical cancer awareness grows, more adults are asking about the HPV vaccine. Experts break down who should get it and how much protection it really offers to adults

From Covid-19 to cancer care: What are mRNA vaccines and how do they work?

mRNA vaccines made headlines during Covid-19, now they could redefine cancer treatment. Here's what Nobel Prize-winning technology is and how it works

Over 14 million infants missed all vaccines in 2024, warn WHO and UNICEF

Despite stable global coverage, over 14 million infants received no vaccines in 2024, a worrying gap as efforts to meet Immunization Agenda 2030 targets remain off-track

India's HPV vaccine rollout brings cervical cancer prevention closer

Studies show that widespread HPV vaccination can reduce infection rates by up to 90% and could nearly eliminate cervical cancer in the coming decades

New blood test from Aiims detects cervical cancer earlier, cheaper: Details

The ₹2,500 test detects HPV DNA in blood, offering early relapse warnings, simpler follow-ups, and a cost-effective alternative to scans and biopsies

Govt plans to train frontline workers ahead of HPV vaccine rollout

The Union Health Ministry is planning to roll out capacity building activities for frontline workers involved in administration of Human Papillomavirus (HPV) vaccination, sources said. In her interim budget speech in 2024, Union minister Nirmala Sitharaman had said that the government will encourage vaccination of girls in the age group of 9-14 years to prevent cervical cancer. According to sources, the Union Health Ministry has held several meetings and is working on a detailed strategy for the implementation of the same. "Roll-out of capacity building activities for the frontline workers and IEC (information education and communications) activities for sensitisation purposes are being planned with respect to HPV vaccination," an official source said. In June 2022, National Technical Advisory Group on Immunisation (NTAGI) had recommended the introduction of HPV vaccine in the Universal Immunisation Programme for adolescent girls in the age group of 9-14 years. Currently, vaccines

Aiims Delhi's multicentre study to develop low-cost cervical cancer tests

According to Global Cancer Observatory (GLOBOCAN) data, an estimated 663,301 women were diagnosed with cervical cancer worldwide in 2022, of which 348,874 women died from the disease

BS 1000: Vaccine maker to logistics major, here're the top unlisted firms

Besides MNCs, the top 30 list also includes two public-sector companies: Orissa Mining Corporation and HLL Life Care

Raise awareness about cervical cancer, importance of HPV vaccine: Centre

The government has asked all states and Union Territories to create awareness on prevention of cervical cancer, the importance of HPV vaccine among girl and organise vaccination camps in schools. The Education and Health Ministry, in a joint letter, have informed states and UTs that the National Technical Advisory Group for Immunization (NTAGI) has recommended introduction of human papillomavirus (HPV) vaccine in the Universal Immunization Programme with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction at nine years. "Globally, cervical cancer is the fourth most common cancer in women. In India, cervical cancer is the second most common cancer in women and India contributes the largest proportion of global cervical cancer burden. "Cervical cancer is a preventable and curable disease as long as it is detected early and managed effectively," said the letter written by Union Education Secretary Sanjay Kumar and Health Secretary Rajesh ...

HPV vaccine prodn delayed due to Covid, to start supply in early 2023: SII

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on COVID, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said. Exports will have to wait till 2024, its chief executive Adar Poonawalla told reporters here on Thursday evening, adding that the company has to build a scale of manufacturing to over 150 million for that. HPV vaccines prevent certain kinds of cervical cancer. SII is the world's largest vaccine manufacturer which rushed with the production of multiple COVID vaccines at its facilities located here once the shot was approved for use. "The HPV facility was used by the COVID vaccines during the pandemic. That's why we had to delay the larger launch to next year," Poonawalla said, speaking on the sidelines of an event. "We will be making a very small quantity and launching with the Indian government in the first quarter of next year. Followed by a capacity for 70

National Immunisation Mission: How indigenous vaccines can go a long way

The locally developed Ceravac can play a critical role in the efficacy of the National Immunisation Mission

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

NIM inclusion of anti-cancer vaccine may start with 9-14 year olds

The inclusion of this vaccine in the NIM is a significant step in reducing cervical cancer burden among women

MSD launches gender-neutral HPV vaccine in India, licences Covid jab

HPV infections are one of the leading causes of cervical cancer in women

Why has the controversy around the HPV vaccine still not died down?

The HPV vaccine, administered to pre-pubescent girls to prevent cervical cancer, has received considerable bad press over its 14 years

Under-14 children need only 2 shots of HPV vaccine doses

To protect against cervical cancer and other cancers caused by the human papillomavirus